Urinary JCV-DNA Testing during Natalizumab Treatment May Increase Accuracy of PML Risk Stratification
暂无分享,去创建一个
L. Grimaldi | G. Palù | F. Bandini | L. Barzon | A. Uccelli | G. Mancardi | A. Laroni | V. Militello | M. Sormani | A. Bertolotto | G. Vitello | F. Rinaldi | E. Capello | M. Pizzorno | I. Gandoglia | J. McDermott | O. Varnier | C. Giacomazzi | I. Martini | P. Gallo